VThunter
a database for single-cell screening of virus target cells in animal kingdom
Pig-tailed macaque

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Cercopithecoidea; Cercopithecidae; Cercopithecinae; Macaca,

Latin Name: Macaca nemestrina

Tested tissues: LateralGeniculateNucleus,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_1018 2018.06 Single nuclei RNA-seq LateralGeniculateNucleus Normal 1092 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Rabies lyssavirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 100.00% ;
LateralGeniculateNucleus-LGN Inh DSEL : 100.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 96.43% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 88.89% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 84.70% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.85% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 23.50% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Influenza A virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 100.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 98.36% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 97.76% ;
LateralGeniculateNucleus-LGN Inh DSEL : 92.98% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 78.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 61.87% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 57.38% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 47.73% ;
LateralGeniculateNucleus-LGN Inh DSEL : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 29.55% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 55.56% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 9.09% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Bovine leukemia virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 100.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 97.81% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 97.73% ;
LateralGeniculateNucleus-LGN Inh DSEL : 96.49% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 96.44% ;
Hepacivirus C
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 96.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 92.98% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 88.89% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 83.06% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 79.02% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 65.91% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 62.40% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 59.56% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 42.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 55.56% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 9.09% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
LateralGeniculateNucleus-LGN Inh DSEL : 38.60% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 29.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 18.73% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 15.91% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 11.36% ;
Feline leukemia virus strain B/lambda-B1
LateralGeniculateNucleus-LGN Exc IL15RA : 91.16% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 83.06% ;
LateralGeniculateNucleus-LGN Inh DSEL : 70.18% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 43.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 39.05% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 38.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 27.87% ;
Gibbon ape leukemia virus
LateralGeniculateNucleus-LGN Exc IL15RA : 91.16% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 83.06% ;
LateralGeniculateNucleus-LGN Inh DSEL : 70.18% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 43.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 39.05% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 38.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 27.87% ;
Simian sarcoma-associated virus
LateralGeniculateNucleus-LGN Exc IL15RA : 91.16% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 83.06% ;
LateralGeniculateNucleus-LGN Inh DSEL : 70.18% ;
Simian rotavirus A strain RRV
LateralGeniculateNucleus-LGN Inh DFNB31 : 90.91% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 90.50% ;
LateralGeniculateNucleus-LGN Inh DSEL : 89.47% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 84.70% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 19.13% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 23.75% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.31% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Oliveros mammarenavirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 85.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 74.32% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
Lymphocytic choriomeningitis mammarenavirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 85.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 74.32% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
Latino mammarenavirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 85.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 74.32% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
Lassa mammarenavirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 88.64% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 85.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 74.32% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.12% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 50.82% ;
LateralGeniculateNucleus-LGN Inh DSEL : 40.35% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 36.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
Enterovirus A71
LateralGeniculateNucleus-LGN Inh DSEL : 87.72% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 77.78% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 77.27% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 76.91% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Coxsackievirus A16
LateralGeniculateNucleus-LGN Inh DSEL : 87.72% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 85.71% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 77.78% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 77.27% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 76.91% ;
Adeno-associated virus - 3
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
Classical swine fever virus
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
Sindbis virus
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
Adeno-associated virus - 8
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
Venezuelan equine encephalitis virus
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
Adeno-associated virus 9
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
Adeno-associated virus - 2
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh DSEL : 61.40% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 58.84% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 57.38% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 56.82% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 35.52% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 28.63% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Dengue virus
LateralGeniculateNucleus-LGN Exc IL15RA : 86.94% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 86.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 82.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 82.14% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 80.87% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
JC polyomavirus
LateralGeniculateNucleus-LGN Inh DSEL : 85.96% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 84.09% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
Vesicular stomatitis virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 78.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 61.87% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 57.38% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 47.73% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Inh DSEL : 38.60% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 29.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 18.73% ;
Human parvovirus B19
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 35.52% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 28.63% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Human gammaherpesvirus 4
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 14.29% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.19% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.02% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Foot-and-mouth disease virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 35.52% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 28.63% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Equid alphaherpesvirus 1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
Echovirus E1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 23.75% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.31% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Echovirus E8
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 23.75% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.31% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Human betaherpesvirus 5
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 55.56% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 9.09% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Ecotropic murine leukemia virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 54.64% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 53.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 49.12% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 45.45% ;
Human rotavirus strain WA
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 19.13% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 23.75% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.31% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Human metapneumovirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 35.52% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 28.63% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Mammalian orthoreovirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 75.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 72.96% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 63.93% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 63.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 50.66% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 49.73% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 19.13% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
Machupo mammarenavirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Argentinian mammarenavirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Mouse mammary tumor virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Feline panleukopenia virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Guanarito mammarenavirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Canine parvovirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 71.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 69.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 55.74% ;
LateralGeniculateNucleus-No Class : 46.15% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 40.91% ;
Human mastadenovirus E
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Coxsackievirus B6
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Human betaherpesvirus 6
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
Bovine viral diarrhea virus 1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
Human mastadenovirus F
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Human betaherpesvirus 6A
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
Coxsackievirus B2
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Coxsackievirus B1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Coxsackievirus B4
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Measles morbillivirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Human mastadenovirus D
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Human mastadenovirus C
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 14.29% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 7.92% ;
Human mastadenovirus A
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
Human mastadenovirus B
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 66.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 61.75% ;
LateralGeniculateNucleus-LGN Inh DSEL : 59.65% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
Coxsackievirus B5
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Coxsackievirus B3
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 67.86% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 42.11% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 33.33% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 30.34% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Severe acute respiratory syndrome coronavirus 2
LateralGeniculateNucleus-LGN Inh DSEL : 66.67% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 65.91% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 62.40% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 59.56% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 42.86% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 22.95% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 17.86% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 11.36% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
Xenotropic murine leukemia virus
LateralGeniculateNucleus-LGN Inh DSEL : 63.16% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 58.05% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 45.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 38.80% ;
Polytropic murine leukemia virus
LateralGeniculateNucleus-LGN Inh DSEL : 63.16% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 58.05% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 45.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 38.80% ;
Human alphaherpesvirus 1
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-No Class : 7.69% ;
West Nile virus
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Human gammaherpesvirus 8
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 39.29% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 29.16% ;
LateralGeniculateNucleus-LGN Inh DSEL : 22.81% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.31% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Coxsackievirus A9
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
Human parechovirus 1
LateralGeniculateNucleus-LGN Exc IL15RA : 57.92% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 54.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 53.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-No Class : 23.08% ;
Varicella Zoster Virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 55.56% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 43.54% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 36.07% ;
LateralGeniculateNucleus-LGN Inh DSEL : 31.58% ;
Human alphaherpesvirus 3
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 55.56% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 50.00% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 43.54% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 36.07% ;
LateralGeniculateNucleus-LGN Inh DSEL : 31.58% ;
Feline leukemia virus strain C/FA27
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 53.57% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 52.27% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 52.11% ;
LateralGeniculateNucleus-LGN Inh DSEL : 50.88% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 41.53% ;
Chikungunya virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 53.57% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 45.45% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 44.06% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 40.98% ;
LateralGeniculateNucleus-LGN Inh DSEL : 38.60% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 13.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Ebola virus
LateralGeniculateNucleus-LGN Exc IL15RA : 51.45% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 50.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 42.62% ;
LateralGeniculateNucleus-LGN Inh DSEL : 36.84% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Hepatitis E virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 31.58% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 28.96% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 20.45% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 20.05% ;
Amphotropic murine leukemia virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 43.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 39.05% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 38.64% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 27.87% ;
Zika virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
Marburg marburgvirus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 46.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 32.45% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 14.75% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 12.57% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.37% ;
LateralGeniculateNucleus-No Class : 15.38% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Human papillomavirus type 16
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 45.90% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 43.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 42.86% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 27.27% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 25.68% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 24.14% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Porcine reproductive and respiratory syndrome virus
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 45.90% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 43.67% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 42.86% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 27.27% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
Enterovirus D68
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 44.44% ;
LateralGeniculateNucleus-LGN Inh DSEL : 17.54% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Human rhinovirus A2
LateralGeniculateNucleus-LGN Inh DSEL : 38.60% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 29.55% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 18.73% ;
Middle East respiratory syndrome-related coronavirus
LateralGeniculateNucleus-LGN Inh DSEL : 36.84% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 20.45% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 19.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 18.58% ;
Feline calicivirus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 33.33% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 19.13% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
Rubella virus
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 32.14% ;
LateralGeniculateNucleus-LGN Inh DSEL : 12.28% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 9.09% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 8.05% ;
Echovirus E33
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E6
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E20
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E12
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E11
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Coxsackievirus A21
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E21
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Human enterovirus 70
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E29
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E13
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Echovirus E7
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 28.57% ;
LateralGeniculateNucleus-No Class : 23.08% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 13.66% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.59% ;
Coxsackievirus A10
LateralGeniculateNucleus-LGN Inh DSEL : 28.07% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.27% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 7.14% ;
Porcine endogenous retrovirus A
LateralGeniculateNucleus-LGN Exc IL15RA : 25.46% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 21.86% ;
LateralGeniculateNucleus-LGN Inh DSEL : 15.79% ;
Suid alphaherpesvirus 1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 20.45% ;
LateralGeniculateNucleus-LGN Inh DSEL : 14.04% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 8.74% ;
Enterovirus C
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 20.45% ;
LateralGeniculateNucleus-LGN Inh DSEL : 14.04% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 8.74% ;
Bovine alphaherpesvirus 1
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 25.00% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 20.45% ;
LateralGeniculateNucleus-LGN Inh DSEL : 14.04% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 12.53% ;
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 8.74% ;
Enterovirus B
LateralGeniculateNucleus-No Class : 23.08% ;
Jaagsiekte sheep retrovirus
LateralGeniculateNucleus-LGN Inh DFNB31 : 22.73% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 21.43% ;
LateralGeniculateNucleus-LGN Inh DSEL : 15.79% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 9.89% ;
Andes orthohantavirus
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 22.40% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 17.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.32% ;
Sin Nombre orthohantavirus
LateralGeniculateNucleus-LGN Exc PRKCG SYNDIG1L : 22.40% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 17.86% ;
LateralGeniculateNucleus-LGN Exc IL15RA : 13.32% ;
Human immunodeficiency virus 2
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Japanese encephalitis virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 9.09% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Human immunodeficiency virus 1
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Rift Valley fever virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Human alphaherpesvirus 2
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Respiratory syncytial virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
LateralGeniculateNucleus-No Class : 15.38% ;
Uukuniemi virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
SARS coronavirus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 22.22% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Murine hepatitis virus
LateralGeniculateNucleus-LGN Exc IL15RA : 15.83% ;
LateralGeniculateNucleus-LGN Inh DFNB31 : 11.36% ;
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
LateralGeniculateNucleus-LGN Inh DSEL : 10.53% ;
Murine norovirus
LateralGeniculateNucleus-No Class : 15.38% ;
Mayaro virus
LateralGeniculateNucleus-LGN Inh DFNB31 : 13.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Ross River virus
LateralGeniculateNucleus-LGN Inh DFNB31 : 13.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Onyong-nyong virus
LateralGeniculateNucleus-LGN Inh DFNB31 : 13.64% ;
LateralGeniculateNucleus-LGN Inh DSEL : 8.77% ;
Hendra henipavirus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Simian immunodeficiency virus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Human betaherpesvirus 7
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
Nipah henipavirus
LateralGeniculateNucleus-LGN Inh TNFAIP8L3 : 11.11% ;
LateralGeniculateNucleus-No Class : 7.69% ;
Rhinovirus C
LateralGeniculateNucleus-LGN Exc PRKCG KCNH3 : 10.71% ;
Baboon endogenous virus strain M7
LateralGeniculateNucleus-No Class : 7.69% ;
Feline endogenous virus RD114
LateralGeniculateNucleus-No Class : 7.69% ;
Simian type D retrovirus -Tsukuba
LateralGeniculateNucleus-No Class : 7.69% ;

Contact Us

E-mail: chendongsheng@genomics.cn

Address: Build 11, Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China

Copyright © VThunter 2020-2021 ShenZhen, Guangdong province, China